In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies. This Center will lead Korea’s development of innovative biotechnologies including genome editing for seven years beginning in 2020 with a budget of 76 billion Korean won (approximately $63 million USD). Korea is coordinating with relevant ministries to set policy on innovative biotechnologies. There has been no improvement on approval of genetically engineered (GE) products. After the detection of GE wheat in the United States in June 2019, the Ministry of Food and Drug Safety (MFDS) has been testing all incoming wheat and wheat flour from the United States to confirm absence of the unapproved GE wheat event. All tests were negative.